Shopping Cart 0
Cart Subtotal
USD 0

Bio Techne Corp (TECH) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company's portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization. It offers Western blot, enzyme-linked immunosorbent assay, and biologics platform. Bio Techne also offers controls and calibrators for hematology clinical instruments. Bio Techne's products find application in scientific investigation of biological processes and also to identify the nature and progress of certain diseases. The company sells its products through an extensive network of distributors across the world. It caters to biotechnology research and clinical diagnostic markets. The company has subsidiaries in the UK, Canada, and China. Bio Techne is headquartered in Minneapolis, Minnesota, the US.

Bio Techne Corp (TECH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Bio Techne Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Bio Techne Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Bio Techne Corp, Medical Equipment, Deal Details 14

Venture Financing 14

Exosome Diagnostics Raises USD60 Million in Series B Financing Round 14

Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 16

Exosome Diagnostics Raises USD1.5 Million in Financing Round 17

Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 18

Exosome Diagnostics to Raise USD25 Million in Venture Financing 19

Zephyrus Biosciences Raises USD0.3 Million in Venture Financing 20

Exosome Diagnostics Raises USD 27 Million In Series B Financing Round 21

Exosome Diagnostics Raises USD 7 Million In Venture Financing 23

Advanced Cell Diagnostics Raises USD 12 Million In Series B Financing 24

Exosome Diagnostics Raises USD3 Million in Venture Financing 25

Partnerships 26

Bio-Techne Enters into Agreement with Micropoint 26

Exosome Diagnostics Enters into Agreement with Intezyne 27

Exosome Diagnostics Enters into Agreement with Merck 28

Exosome Diagnostics Enters into Agreement with Amgen 29

Exosome Diagnostics Enters into Agreement with Takeda Pharma 30

Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 31

Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 32

Luminex Enters into Distribution Agreement with Bio-Techne 33

Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 34

Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 35

MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 36

Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 37

Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 38

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 39

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 40

Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 41

Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 42

Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 43

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 44

Equity Offering 45

Astute Medical Raises USD43 Million in Private Palcement of Shares 45

ProteinSimple Withdraws IPO 46

Acquisition 47

Bio-Techne Acquires Exosome Diagnostics 47

Bio Techne Acquires Trevigen 48

Bio-Techne Acquires Advanced Cell Diagnostics 49

Bio-Techne Acquires Space Import-Export for USD9 Million 51

Bio-Techne Acquires Cliniqa 52

Bio-Techne Acquires Cyvek 53

Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 54

Techne Completes Acquisition Of Bionostics For USD 104 Million 56

Bio Techne Corp-Key Competitors 58

Bio Techne Corp-Key Employees 59

Bio Techne Corp-Locations And Subsidiaries 60

Head Office 60

Other Locations & Subsidiaries 60

Recent Developments 62

Financial Announcements 62

Aug 07, 2018: Bio-Techne releases fourth quarter fiscal 2018 results 62

May 02, 2018: Bio-Techne Releases Third Quarter Fiscal 2018 Results 65

Feb 06, 2018: Bio-Techne Reports Net Sales Of USD 154.2 million In The Second Quarter Of Fiscal 2018 67

Oct 31, 2017: Bio-Techne Releases First Quarter Fiscal 2018 Results 69

Aug 08, 2017: Bio-Techne Releases Fourth Quarter Fiscal 2017 Results 71

May 02, 2017: Bio-Techne Releases Third Quarter Fiscal 2017 Results 74

Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 76

Corporate Communications 78

Apr 24, 2018: Bio-Techne Appoints Kim Kelderman As President, Diagnostics and Genomics 78

Oct 26, 2017: Bio-Techne Adds Two New Directors to Its Board 79

Product News 80

Jun 26, 2018: Bio-Techne Expands RNAscope Assay Services Portfolio to Shorten Development Times and Save Costs 80

Mar 14, 2018: Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract 81

Nov 20, 2017: Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design 82

Other Significant Developments 83

Mar 21, 2018: Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) technology with the launch of several new and updated assays 83

Jan 30, 2018: Bio-Techne's Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms 84

Jan 15, 2018: Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne 85

Jan 11, 2017: COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator 86

Appendix 87

Methodology 87

About GlobalData 87

Contact Us 87

Disclaimer 87


List Of Figure

List of Figures

Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Bio Techne Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Bio Techne Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

Bio Techne Corp, Medical Equipment, Key Facts, 2018 2

Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Bio Techne Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Bio Techne Corp, Deals By Market, 2012 to YTD 2018 10

Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Exosome Diagnostics Raises USD60 Million in Series B Financing Round 14

Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 16

Exosome Diagnostics Raises USD1.5 Million in Financing Round 17

Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 18

Exosome Diagnostics to Raise USD25 Million in Venture Financing 19

Zephyrus Biosciences Raises USD0.3 Million in Venture Financing 20

Exosome Diagnostics Raises USD 27 Million In Series B Financing Round 21

Exosome Diagnostics Raises USD 7 Million In Venture Financing 23

Advanced Cell Diagnostics Raises USD 12 Million In Series B Financing 24

Exosome Diagnostics Raises USD3 Million in Venture Financing 25

Bio-Techne Enters into Agreement with Micropoint 26

Exosome Diagnostics Enters into Agreement with Intezyne 27

Exosome Diagnostics Enters into Agreement with Merck 28

Exosome Diagnostics Enters into Agreement with Amgen 29

Exosome Diagnostics Enters into Agreement with Takeda Pharma 30

Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 31

Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 32

Luminex Enters into Distribution Agreement with Bio-Techne 33

Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 34

Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 35

MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 36

Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 37

Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 38

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 39

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 40

Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 41

Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 42

Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 43

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 44

Astute Medical Raises USD43 Million in Private Palcement of Shares 45

ProteinSimple Withdraws IPO 46

Bio-Techne Acquires Exosome Diagnostics 47

Bio Techne Acquires Trevigen 48

Bio-Techne Acquires Advanced Cell Diagnostics 49

Bio-Techne Acquires Space Import-Export for USD9 Million 51

Bio-Techne Acquires Cliniqa 52

Bio-Techne Acquires Cyvek 53

Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 54

Techne Completes Acquisition Of Bionostics For USD 104 Million 56

Bio Techne Corp, Key Competitors 58

Bio Techne Corp, Key Employees 59

Bio Techne Corp, Subsidiaries 60

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Bio Techne Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.